1.
Greening the Health Sector Pharmaceuticals andc Climate Change c c Dr. Christoph Hamelmann Regional Practice Leader HIV, Health and Development UNDP Europe and Central Asia CIS Pharmaceutical Forum Moscow, Russia, 5 January 2013

2.
Likely Temperature Increaseby GHG Emission Pathways

3.
Energy Intensity (Energy consumption per unit GDP 2011, ENERDATA)Countries Energy Intensity World Major Country Ranking (highest 4)Uzbekistan 0.633 1Ukraine 0.436 2Kazakhstan 0.399 3Russia 0.346 4

4.
GHG Emission Reduction Pledges CIS CountriesCountries Unconditional Pledge Conditional Pledge Current GHG Emissions (MtCO2e 2010)Armenia - Submitted policy actions 11Azerbaijan - - 50Belarus Reduction 8 % below 1990 level by 2020 - 150Kazakhstan Reduction 15 % below 1990 level by 2020 - 318Kyrgyzstan - - ?Moldova Reduction 25 % below 1990 level by 2020 - 11Russia Reduction 15 % below 1990 level by 2020 Reduction 25 % below 2510 1990 level by 2020Tajikistan - Submitted policy actions 15Uzbekistan - - 174Turkmenistan - - 87Ukraine Reduction 20 % below 1990 level by 2020 - 397

5.
Health Sector in the ECIS Region • Accounts for 7.5 % of GDP • Technology intensive with significant consumption of resources, associated with environmental pollution and degradation • Accounts for an estimated 4.2 % of greenhouse gases (GHG) in the ECIS region • Up to 25 % of these GHG can be reduced within short-term, more through long-term measures • Reductions have also direct positive impact on life-years savedMinisterial European Environment and Health Task Force Meeting, Bled / Slovenia 2011

6.
NHS Carbon Footprint Breakdown 2010

7.
European Ministerial Environment & Health Task Force Fifth Ministerial Conference on Environment and Health Parma 2010 53 member states, including all CIS countries + others

8.
Sector Guidance on Carbon Foot-Printing• Cross-sectoral partnership• Standardized quantification of the GHG inventory of pharmaceutical products certified by international GHG protocol• Identification of hot spots throughout the product life cycle• Focus on minimizing carbon footprint for producers, buyers and users of pharmaceutical products http://www.sdu.nhs.uk/pharma-md

9.
Marginal Abatement Costs

10.
Gaining Efficiencies – Reducing GHG Emissions Lessons Learnt From Pharma-Industry

11.
Stay competitive!

12.
ESA

13.
Economic Commission for Europe Report Regional Preparatory Meeting Public procurement47. Sustainable public procurement was supported as afirst critical step to further the green economy at thenational as well as the sub-national level. Concreteprogress was proposed in the form of sustainable publicprocurement targets that could be met by an increasingnumber of countries over the years.

14.
Leadership and Innovations

15.
Thank You!christoph.hamelmann@undp.org Twitter: @cahamelmann